CRBU

Caribou Biosciences, Inc.

A clinical-stage biotech building "off-the-shelf" CAR-T cell therapies that treat blood cancers using healthy donor cells instead of a patient's own, with two candidates in early trials. It was founded in Berkeley in 2011 by CRISPR pioneer and Nobel laureate Jennifer Doudna and her team, and the name "Caribou" nods to the CRISPR enzymes behind its work. Insiders even joke that its chRDNA editing technology sounds like "chardonnays," the wine.

CUSIP: 142038108HealthcareUS1 holder

Ownership Activity Financials Filings

CRBU

CRBU

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition